A novel antioxidant formulation designed to treat male infertility associated with oxidative stress: promising preclinical evidence from animal models
Human Reproduction2016Vol. 31(2), pp. 252–262
Citations Over TimeTop 1% of 2016 papers
P. Gharagozloo, Alfonso Gutiérrez‐Adán, Alexandre Champroux, Anaïs Noblanc, A. Kocer, A. Calle, Serafín Pérez‐Cerezales, Eva Pericuesta, Ashley Polhemus, Aron Moazamian, J.R. Drevet, R. John Aitken
Abstract
The study was funded by the Clermont Université and the University of Madrid. P.G. is the Managing Director of CellOxess LLC, which has a commercial interest in the detection and resolution of oxidative stress. A.M. and A.P. are employees of CellOxess, LLC. J.R.D., A.G.-A. and R.J.A. are honorary members of the CellOxess advisory board.
Related Papers
- → <p>Some of the Factors Involved in Male Infertility: A Prospective Review</p>(2020)274 cited
- → Male Infertility and Its Causes in Human(2011)85 cited
- → Relationship between hemoglobinopathies and male infertility: a scoping review(2024)4 cited
- → New perspectives in male infertility(2017)2 cited
- → Male infertility and gene defects(2010)